Purity, recovery and the caveats that come with them — separated samples measured with the gate strategy and the sample written down, including the cases where a number should not be extrapolated.
Every entry reports the starting frequency, the format used and what the flow-through contained. Customer samples are anonymised; internal validation is labelled as such.
anti-mouse CD19 Nanobeads (PM019) on mouse liver: 8 mice pooled yielded 8x10^6 cells; after column selection 87.02% of live cells were CD45+CD19+, with a gating chain of 96.27% / 89.36% / 91.26% / 87.02%. Includes three practical notes on hepatic B-cell isolation.
anti-mouse CD8 Nanobeads (PM008) depleting CD4+CD8+ double-positive cells from mouse thymus: residual CD8+ in the flow-through 13.92% versus 67.50% for the competitor at the same bead dose; positive-selection purity was comparable at 98.95% and 99.53%.
Human peripheral blood separated with anti-human CD66b Nanobeads: CD66b⁺ cells rose from 55.7% to 99.3% after one column in lysed blood; in whole blood CD45⁺ cells went from 15% to 93.5% and CD66b⁺ inside the CD45 gate from 88.0% to 99.9%. One protocol serves both enrichment and depletion, with two documented routes — 11 steps after red-cell lysis or 6 steps on whole blood (manual v26.01).
English summaryMouse spleen separated with anti-mouse CD19 Nanobeads: CD19⁺ cells rose from 55.6% to 94.4% after one column, leaving 1.54% in the flow-through, so one protocol covers both enrichment and depletion. Includes the CD19 expression boundary (plasma cells negative, follicular dendritic cells positive), the separation principle, raw flow plots, bead dosing by starting frequency and the seven-step protocol (manual v26.01).
English summaryMouse spleen separated with anti-mouse CD49b Nanobeads: CD49b⁺ cells rose from 3.54% to 87.6% after one column (about 24.7-fold enrichment) with 1.28% remaining in the flow-through, so one protocol covers both enrichment and depletion. Includes the separation principle, raw flow plots, bead dosing, a seven-step protocol and the manual update to v26.02.
English summaryA parallel split-sample comparison on mouse spleen DCs, acquired to 10,000 events: CD11c⁺ purity reached 85.5% against 70.1% for the imported reference — a 15.4 percentage-point gain (+22% relative). Gates were not pre-gated on CD45; no absolute counts were recorded, so yield is not calculated.
English summaryNaive CD4⁺ T cells from C57BL/6J spleen, activated with CD3/CD28 beads and polarised for five days in 48-well plates: CD4⁺IFN-γ⁺ rose from 0.010% to 50.7% with DM102, and CD4⁺IL-4⁺ from 0.76% to 18.0% with DM103. Intracellular staining after permeabilisation; uninduced controls shown alongside.
English summaryMouse bone-marrow CD117⁺ cells sit at roughly 10–30% of the suspension. One column gives an enriched fraction for CFU assays or flow sorting, and the flow-through is a ready CD117-depleted counterpart; the manual quotes purity up to 85%. CD117⁺ is a progenitor pool, not a stem-cell definition — LSK is closer to the stem fraction.
English summaryKG-1 is a myeloid line that resists VSV-G pseudotypes. At MOI 50 the engineered envelope raised transduction from 22.8% to 47.4% (about 2.1-fold) under otherwise identical conditions; LVh45 reached 44.1%. A relative comparison inside one cell-line model, not a promise for primary HSC.
English summaryColumn-based positive selection of human CD8⁺ T cells from PBMC, covering bead dosing, column loading and the purity readout, with notes on panel design when the target antigen itself is the readout.
English summaryA rare starting population: CD34⁺ cells at 0.15% reached 45.58% after the first column (about 304-fold) and 86.14% after a second column on a fresh cartridge (about 574-fold). No absolute counts were recorded, so no yield is reported.
English summaryA single mouse sample separated on a column: CD45⁺ cells went from 8.87% before separation to 95.0% in the positive fraction (10.7-fold, +86.13 pp), with 0.33% residual in the flow-through (96.3% relative depletion). That residual corresponds to about 24 events inside the gate.
English summarySplit-sample comparison: fresh PBMC reached 87.10% vs 83.54% for the imported reference (+3.56 pp, +4.26% relative), frozen aliquots 91.43% vs 85.85% (+5.58 pp, +6.50% relative). Both vendors scored higher on frozen material, so purity is not comparable across batches — compare within a batch only.
English summary9 articles in this section. Every article has an English page — each card opens it, with the same figures and the same caveats.
Tell us your cell type, sample source and downstream assay — we will suggest an isolation route, a culture condition and the matching catalogue numbers.